The newly approved oral formulation features a smaller pill size in 1.5mg, 4mg, and 9mg strengths while maintaining the efficacy and safety profile of the previous oral semaglutide version.
Sleep Apnea Solution author Dylan Petkus, MD, has developed a non-device, behavior-based alternative approach to sleep apnea.